Viral Infections
RSSArticles
-
Lung Health Program Revamped to Help Manage COVID-19 Pandemic
A Maryland hospital adapted an existing program encouraging lung health to respond to the sudden demands of COVID-19. The program helped reduce COVID-19 readmission rates by two-thirds.
-
Bamlanivimab and Etesevimab Injection
Bamlanivimab and etesevimab should be prescribed to treat mild-to-moderate COVID-19 in adults and pediatric patients (age 12 years and older, weight at least 40 kg) who test positive for COVID-19 and are at high risk for progressing to severe disease and/or hospitalization.
-
How to Safely Open Schools in the Time of COVID-19
Multiple COVID-19 transmission clusters were identified in a Georgia school district, with educators often the index cases. The CDC has provided recommendations for safely opening schools.
-
COVID-19 Long-Haulers May Show Signs of Chronic Fatigue, Myalgic Encephalitis
Many patients with COVID-19 will go on to develop persisting symptoms that resemble those of myalgic encephalitis/chronic fatigue syndrome, regardless of symptoms experienced at viral onset.
-
Study: Surgery Centers Handled COVID-19 Patients Safely
Data suggest there may be no increased risk for an asymptomatic, COVID-19-positive patient to go forward with surgery, although more research is needed before surgeons can create evidence-based guidelines.
-
AstraZeneca Reports 79% Efficacy for U.S. COVID-19 Vaccine Candidate
But NIH raises questions the about data.
-
Early Convalescent Plasma to Treat COVID-19 in Elderly Patients with Mild Symptoms
Administering convalescent plasma obtained from survivors of COVID-19 within 72 hours of onset of mild symptoms in elderly patients with the virus was associated with a significant reduction in the risk of development of severe respiratory disease.
-
COVID-19 Patients Can Be Managed Safely with Noninvasive Respiratory Techniques
In adult patients hospitalized with COVID-19 for one month, using a noninvasive respiratory protocol that encouraged high-flow nasal cannula, noninvasive mechanical ventilation, and self-proning did not result in any significant increase in mortality.
-
Healthcare Workers with COVID-19 Antibodies: Strong Protection Against Reinfection
A study of healthcare workers demonstrated the presence of antibody to SARS-CoV-2 spike protein or to nucleocapsid provides strong protection against infection for up to six months.
-
FDA, CDC Sign Off on Third COVID-19 Vaccine
Johnson & Johnson’s COVID-19 vaccine is the first single-shot solution to receive an agency emergency use authorization.